MedPath
NMPA Approval

Compound Mifepristone Tablets

国药准字H20040365

October 30, 2023

Drug Information

复方米非司酮片

紫韵

紫韵

片剂

每片含米非司酮30mg,双炔失碳酯5mg。

化学药品

October 30, 2023

Company Information

Applicant Company

武汉东湖新技术开发区光谷七路77号

Manufacturing Company

武汉东湖新技术开发区光谷七路77号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方米非司酮片 - NMPA 批准文号 | MedPath